These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24535283)

  • 1. Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.
    Reue K; Lee JM; Vergnes L
    Curr Opin Lipidol; 2014 Apr; 25(2):140-7. PubMed ID: 24535283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.
    Vergnes L; Lee JM; Chin RG; Auwerx J; Reue K
    Cell Metab; 2013 Jun; 17(6):916-928. PubMed ID: 23747249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.
    Reue K; Lee JM; Vergnes L
    Dig Dis; 2015; 33(3):307-13. PubMed ID: 26045262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants.
    Lee JM; Ong JR; Vergnes L; de Aguiar Vallim TQ; Nolan J; Cantor RM; Walters JRF; Reue K
    J Lipid Res; 2018 Mar; 59(3):429-438. PubMed ID: 29295820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
    Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
    FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
    Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.
    Gulfo J; Rotondo F; Ávalos de León CG; Cornide-Petronio ME; Fuster C; Gracia-Sancho J; Jiménez-Castro MB; Peralta C
    J Hepatol; 2020 Nov; 73(5):1131-1143. PubMed ID: 32422221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus.
    Liu S; Marcelin G; Blouet C; Jeong JH; Jo YH; Schwartz GJ; Chua S
    Mol Metab; 2018 Feb; 8():37-50. PubMed ID: 29290621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.
    Uriarte I; Fernandez-Barrena MG; Monte MJ; Latasa MU; Chang HC; Carotti S; Vespasiani-Gentilucci U; Morini S; Vicente E; Concepcion AR; Medina JF; Marin JJ; Berasain C; Prieto J; Avila MA
    Gut; 2013 Jun; 62(6):899-910. PubMed ID: 23292666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Messengers: fibroblast growth factor 15/19.
    Gadaleta RM; Moschetta A
    Nat Metab; 2019 Jun; 1(6):588-594. PubMed ID: 32694803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease.
    Jahn D; Rau M; Hermanns HM; Geier A
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):625-35. PubMed ID: 26250749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
    Schaap FG
    Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice.
    Slijepcevic D; Roscam Abbing RLP; Katafuchi T; Blank A; Donkers JM; van Hoppe S; de Waart DR; Tolenaars D; van der Meer JHM; Wildenberg M; Beuers U; Oude Elferink RPJ; Schinkel AH; van de Graaf SFJ
    Hepatology; 2017 Nov; 66(5):1631-1643. PubMed ID: 28498614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling.
    Wang LX; Frey MR; Kohli R
    Front Endocrinol (Lausanne); 2021; 12():799648. PubMed ID: 35116006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Accumulation of Novel Fluorine (
    Metry M; Felton J; Cheng K; Xu S; Ai Y; Xue F; Raufman JP; Polli JE
    Mol Pharm; 2018 Nov; 15(11):4827-4834. PubMed ID: 30247920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.